Mental illness, synapses and the brain behavioral disorders by a system of molecules within a system of neurons?

Pharmacopsychiatry

Volumn 43, Issue SUPPL 1, 2010, Pages

  Tretter, F ^a  

^a Isar Amper Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BRAIN RECEPTOR; DOPAMINE; GLUTAMIC ACID; GLYCINE; HISTAMINE; NORADRENALIN; OPIATE; SEROTONIN;

BEHAVIOR DISORDER; BRAIN; BRAIN CORTEX; BRAIN FUNCTION; CLINICAL FEATURE; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; GABAERGIC TRANSMISSION; HUMAN; MEMORY; MENTAL DISEASE; MENTAL FUNCTION; MOLECULAR SYSTEMATICS; NERVE CELL NETWORK; NEUROPSYCHIATRY; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; SYNAPSE;

ANIMALS; BRAIN; HUMANS; MENTAL DISORDERS; MODELS, NEUROLOGICAL; NEURONS; SYNAPSES;

EID: 77952966599     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1253365     Document Type: Review

References (108)

1. Abbot LF. Balancing homeostasis and learning in neural circuits. Zoology 2003 106 4 365-371
2. Abbott LF, Regehr WG. Synaptic computation. Nature 2004 431 7010 796
3. Abbott LF, Varela J, Sen K, etal. Synaptic depression and cortical gain control. Science 1997 275 220-224
4. Aghajanian GK, Marek GJ. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev 2000 31 23 302-312
5. Alon U. Systems Biology Design principles of biological circuits. New York Chapman & Hall 2007
6. Bender W, Albus M, Mller HJ, etal. Towards systemic theories in biological psychiatry. Pharmacopsychiatry 2006 39 S4-S9
7. Benes FM. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate or something else? Biol Psychiatry 2009 65 1003-1005
8. Benoit-Marand M, Borrelli E, Gonomn F. Inhibition of dopamine release via presynaptic D2 receptors: time course asnd functional characteristics in vivo. J Neurosci 2001 21 9134-9141
9. Bertram R, Sherman A, Stanley EF. Single-domain/bound calcium hypothesis of transmitter release and facilitation. J Neurophysiol 1996 75 1919-1931
10. Best JA, Nijhout HF, Reed MC. Homeostatic mechanisms in dopamine synthesis and release: a mathematical model. Theoretical Biology and Medical Modelling 2009 6 21
11. Brunel N, Wang X-J. Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition. J Comput Neurosci 2001 11 63-85
12. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988 1 179-186
13. Carlsson A. The neurochemical circuitry of schizophrenia. Pharamcopsychiatry 2006 39 Suppl. 1 S10-S14
14. Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990 13 272-276
15. Carlsson A, Waters N, Carlsson ML. Neurotransmitter interactions in schizophrenia- therapeutic implications. Eur Arch Psychiat Clin Neurosci 1999 249 37-43
16. Carlsson A, Waters N, Holm-Waters S, etal. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 2001 41 237-260
17. Chavas J, Marty A. Coexistence of Excitatory and Inhibitory GABA Synapses in the Cerebellar Interneuron Network. J Neurosci 2003 23 6 2019-2031
18. Clements JD. Transmitter timecourse in the synaptic cleft: its role in central synaptic function, Trends. Neurosci 1996 19 5 163-171
19. Cohen JD, Servan-Schreiber D. A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophr Bull 1993 19 85-104
20. Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology. 8th ed., New York Oxford University Press 2004
21. Cragg SJ, Rice ME. Dancing past the DAT at a DA synapse. Trends Neurosci 2004 27 5 270-277
22. Dayan P, Abbott LF. Theoretical Neuroscience Computational and mathematical modeling of neural systems. Cambridge, MA MIT Press 2005
23. Durstewitz D. A few important points about dopamine's role in neural network dynamics. Pharmacopsychiatry 2006 39 S72-S75
24. Durstewitz D, Seamans JK. The computational role of dopamine D1 receptors in working memory. Neural Netw 2002 15 46 561-572 Review
25. Durstewitz D, Seamans JK, Sejnowski TJ. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 2000 83 1733-1750
26. Fernandez E, Schiappa R, Giraul JA, etal. DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput Biol 2006 2 12 e176
27. Fishwick PE. ed Handbook of dynamic system modeling. New York Chapman & Hall 2007
28. von Foerster H. Understanding Understanding: Essays on Cybernetics and Cognition. Berlin Springer 2002
29. Freeman WJ. Neurodynamics: An exploration in mesoscopic brain dynamics. Berlin Springer 2000
30. Gallinat J, Obermayer K, Heinz A. Systems Neurobiology of the dysfunctional brain. Pharmacopsychiatry 2007 40 S40-S44
31. Gao W-J, Goldman-Rakic PS. Selective modulation of excitatory and inhibitory microcircuits by dopamine. PNAS 2003 100 5 2836-2841
32. Gebicke-Haerter P. Systems Biology in Molecular Psychiatry. Pharmacopsychiatry 2008 41 S19-S27
33. Giuditta A, Chun JT, Eyman M, etal. Local gene expression in axons and nerve endings:the glia-neuronunit. Physiol Rev 2008 89 515-555
34. Goldman-Rakic PS. Cellular basis of working memory. Neuron 1995 14 477-485
35. Goldman-Rakic PS. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 1999 456 650-661
36. Goldman-Rakic SP, Muly EC III, Williams GV. D1 receptors in prefrontal cells and circuits. Brain Research Rev 2000 31 295-301
37. Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neurosci 1991 41 1-24
38. th Generation of Progress. 2000
39. Grant SGN. Systems biology in neuroscience: bridging genes to cognition. Curr Opin Neurobiol 2003 13 5 577-582
40. Haken H. Brain dynamics. Berlin Springer 2002
41. Hermandez-Lopez S, Bargas J, Surmeier DJ, etal. D1 recpetor activation enhances evoked discharges in neotriatal medium spiny neurons by modulating an L-type Ca2+ conductace. J Neurosci 1997 17 3334-3342
42. Hoffman RE, Dobscha SK. Cortical pruning and the development of schizophrenia: a computer model. Schizophr Bull 1989 15 3 477-490
43. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 2007 8 844-858
44. Kitano H. Computational Systems Biology. Nature 2002 420 6912 206-210
45. Kitano H. Systems Biology: a brief overview. Science 2002 295 5560 1662-1664
46. Klingauf J, Neher E. Modeling buffered Ca2+ diffusion near the membrane: Implications for secretion in neuroendocrine celly. Biophys J 1997 72 674-690
47. Klipp E, Herwig R, Kowald A, etal. Systems Biology in Practice. Weinheim Wiley-VCH 2005
48. Klipp E, Liebermeister W, Wierling Ch, etal. Systems Biology. A Textbook Weinheim Wiley-VCH 2009
49. Koshkina E. Extracellular dopamine concentration control: computational model of feedback control. 2006 URL: http://hdl.handle.net/1860/1160
50. LeNovere N. The long journey to a Systems Biology of neuronal function. BMC Syst Biol 2007 1 28
51. LeNovere N. Neurological disease: are systems approaches teh way forward? Pharmacopsychiatry 2008 41 S28-S31
52. Lewis DA, Pierri JN, Volk DW. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 1999 46 616-626
53. Lewis DL, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005 6 312-324
54. Lindskog M. Modelling of DARPP32 regulation to understand intracellular signaling in pschiatric disorder. Pharmacopsychiatry 2008 41 S99-S104
55. Lindskog M, Kim MS, Wikstrom MA, etal. Transient Calcium and Dopamine Increase PKA Activity and DARPP-32 Phosphorylation. PLoS Comput Biol 2006 2 9 e119
56. Lisman JE, Coyle JT, Green RW, etal. Circuit-based framework fro understanding neurotransmitter and rsik gene interactions in schizophrenia. Trends Neurosci 2008 31 5 234-242
57. Markram H. Blue Brain Project. 2010 http:&bluebrain.epfl.ch/ page18900.html
58. Markram H, Gupta A, Uziel A, etal. Information processing with frequency-dependent synptic connections. Neurobiol Learn Mem 1998 70 101-112
59. Marty A, Llano I. Excitatory effects of GABA in established brain networks. Trends Neurosci 2005 28 6 284-289
60. Meisenzahl EM, Scheuerecker J, Schmitt GJS, etal. Dopamine, prefrontal cortex and working memory functioning in schizophrenia. Pharmacopsychiatry 2007 40 S62-S72
61. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006 10 818-827
62. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003 40 881-884
63. Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology. Biol Psychiatry 1999 46 40-55
64. Nakano T, Doi T, Yoshimoto J, etal. A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity. PLoS Comput Biol 2010 6 2 e1000670
65. Neve KA, Seamans JK, Trantham-Davidson H. Dopamine Receptor. J Recept Signal Transduct Res 2004 24 3 165-205
66. Nicola SM, Surmeier J, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000 23 185-215
67. NIH. Systems Biology. http://www.nigms.nih.gov/Initiatives/SysBio/ 2007
68. NISB. Netherlands Institute for Systems Biology. 2009 http://www.neurosciencecampus-amsterdam.nl/en/index.asp
69. Noble D. Multilevel modelling in Systems Biology: From Cells to Whole Organs. In: Szallasi Z Periwal V Stelling J (Ed) System, modelling in Cellular Biology. Cambridge, MA MIT Press 2006 297-312
70. Noble D. The Music of Life: Biology Beyond the Genome. New York Oxford University Press 2006
71. Palsson BO. Systems Biology. Cambridge Cambridge University Press 2006
72. Pocklington AJ, Armstrong JD, Grant SGN. Organization of brain complexity synapse proteome form and function. Brief Funct Genomic Proteomic 2009 5 I 66-73
73. Pocklington AJ, Cumiskey M, Armstrong JD, etal. The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol Syst Biol 2006 2 2006.0023
74. Qi Z, Miller G, Voit E. A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia. Pharmacopsychiatry 2008 41 S89-S98
75. Reckow S, Gormanns P, Holsboer F, etal. Psychiatric disorders biomarker identification From proteins to systems biology. Pharmacopsychiatry 2008 41 S70-S77
76. Scherer J, Eberle E, Tretter F. A basic mathematical model of the dopamine synapse. In: Trappl R Hrsg. Cybernetics and Systems. Vol I. Vienna Austrian Society for Cybernetic Studies 2002 335-328
77. Schmitz Y, Schmauss C, Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 2002 22 18 8002-8009
78. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progr Neurobiol 2004 74 1-58
79. Seamans JK, Durstewitz D, Christie B, etal. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA 2001 98 301-306
80. Shepherd G. Neurobiology. New York Oxford University Press 1994
81. Shepherd G. The synaptic organization of the brain. New York Oxford University Press 2004
82. Shiflet AB, Shiflet GW. Introduction to computational science. Modeling and simulation for the sciences Princeton, NJ Princeton University Press 2006
83. Sjstrom PJ, Rancz EA, Roth A, etal. Dendritic excitability and synaptic plasticity. Physiol Rev 2008 88 769-840
84. Szallasi Z, Stelling J, Periwal V. (Ed) System modeling in cellular biology. Cambridge, MA, MIT Press 2006
85. Tarazi FI, Baldessarini RJ. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry 1999 4 529-538
86. Trantham-Davidson H, Neely LC, Seamans JK. Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 2004 24 47 10652-10659
87. Tretter F. Systemtheorie im klinischen Kontext. Lengerich Pabst Science Publisher 2005
88. Tretter F, Albus M. Systems biology and psychiatry modeling molecular and cellular networks of mental disorders. Pharmacopsychiatry 2008 41 Suppl S2-S18
89. Tretter F, Gebicke-Haerter P. Neuropsychaitry subject, concepts, methods and computational models. In: Tretter F, Gebicke-Haerter P, Mendoza E, Winterer G. Sysetms Biology in Psychiatric Research. Weinheim Wiley-VCH (in press)
90. Tretter F, Gebicke-Haerter PJ. Philosophy of neuroscience and options of systems science. Pharmacopsychiatry 2009 42 S2-S10
91. Tretter F, Mller W, Carlsson A. (Eds) Systems Science, Computational Science and Neurobiology of Schizophrenia. Pharmacopsychiatry 2006 39 S1-S88
92. Tretter F, Mller W. (Eds) Computational Neuropsychiatry: The Functional Architecture of Working Memory Networks in Schizophrenia Data and Models. Pharmacopsychiatry 2007 40 S1-S94
93. Tretter F, Gallinat J, Mller WE. (Eds) Systems Biology and Psychiatry: The functional architecture of molecular networks in mental disorerders data and models. Pharmacopsychiatry 2008 41 Suppl1 S1-S106
94. Tretter F, Gebicke-Haerter P, Heinz A. (Eds) Systems Biology of Addiction. Pharmacopsychiatry 2009 42 S1-S152
95. Valor LM, Grant SGN. Integrating synapse proteomics with transcritpional regulation. Behav Gent 2007 37 18-30
96. Vernalaken I, Grnder G, Cumming P. Progress in psychopharmacotherapy through molecular imaging. In: Tretter F Gebicke-hrter P Mendoza E Winterer G (ed) Systems Biollogy in Psychiatric Research. Weinheim Wiley-VCH (in press)
97. Vogels TP, Abbott LF. Gating deficits in model networks: a path to schizophrenia? Pharmacopsychiatry 2007 40 S73-S77
98. Wang M, Vijayraghavan S, Goldman-Rakic PS. Selective D2 Receptor Actions on the Functional Circuitry of Working Memory. Science 2004 303 853-856
99. Wang XJ, Tegnr J, Constandinidis C, etal. Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. PNAS 2004 101 5 1368-1373
100. Wang XJ. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia. Pharmacopsychiatry 2006 39 S80-S87
101. Wassef A, Baker J, Kochan LD. GABA and schizophrenia: a review of basic science and clinical studies. J Clin Psychopharmacol 2003 23 6 601-640
102. Wegener N, Koch M. Neurobiology and systems physiology of the endocannabinoid system. Pharmacopsychiatry 2009 42 S79-S86
103. Wightman RM, Heien ML, Wassum KM, etal. Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur J Neurosci 2007 26 2046-2054
104. Winterer G. Cortical microcircuits in schizophrenia the dopamine hypothesis revisited. Pharmacopsychiatry 2006 39 S68-S71
105. Winterer G. Prefrontal dopamine signaling in schizophrenia the corticocentric model. Pharmacopsychiatry 2007 40 S45-S53
106. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 2004 27 11 683-690
107. Yang ChR. Chen Targeting Prefrontal Cortical Dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment. Neuroscientist 2005 11 452-470
108. Zeigler BP, Praehofer H, Kim TG. Theory of modelling and simulation. London Elsevier Academic Press 2000